CRISPR/Cas9 technology generated a single base change resulting in a cysteine to tryptophan conversion at position 188 (C188W) in exon 5. Three additional silent changes were made to disrupt the PAM and prevent retargeting and to generate a diagnostic Pstl site. This is a variant associated with trigeminal neuralgia. (J:299761)